, which bills itself as an AI solutions provider for radiologists, today announced that the U.S. Food and Drug Administration has allowed the use of its algorithms for “adjunctive” detection of findings associated with COVID-19. The models aren’t meant to replace traditional COVID-19 diagnostic tests, like serological tests and nasopharyngeal swabs, but the agency’s allowance acknowledges they could be used to prioritize incidental (i.e., non-specific) CT findings tied with COVID-19 infections.

While the U.S. Centers for Disease Control and Prevention (CDC) recommends against the use of CT scans or X-rays for COVID-19 diagnosis, as does the American College of Radiology (ACR) and radiological organizations in Canada, New Zealand, and Australia, others assert systems from companies like , , , , , , and now Aidoc

Read More At Article Source | Article Attribution